United States Biotechnology & Medical Research

Checkpoint Therapeutics Inc (CKPT)

Ticker: CKPT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Checkpoint Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.5
Fortress Biotech, Inc. Large shareholder
Transaction date
Sale
Price
31.11
Quantity 33,730 +3.2%
Value US$3,962,542
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
220.00
Quantity 6,525 -5.8%
Value US$3,644,187
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
154.36
Quantity 66,455 +31.2%
Value US$1,700,838
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
3.15
Quantity 10,331 -0.3%
Value US$32,543
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
3.41
Quantity 9,233 -0.2%
Value US$31,485
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
3.67
Quantity 74,110 -4.8%
Value US$271,984
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
3.38
Quantity 220,230 -6.4%
Value US$744,377
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
3.87
Quantity 602,167 -15.0%
Value US$2,330,386
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
4.01
Quantity 268,432 -20.6%
Value US$1,076,412
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
2.05
Quantity 24,610 -1.2%
Value US$50,450
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
2.06
Quantity 13,038 -1.9%
Value US$26,858
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
2.07
Quantity 2,035 -1.4%
Value US$4,212
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
2.06
Quantity 5,894 -1.7%
Value US$12,142
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
2.01
Quantity 11,900 -3.1%
Value US$23,919
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
1.95
Quantity 4,115 -2.7%
Value US$8,024
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
5.00
Quantity 3,591 -6.5%
Value US$17,955
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
5.00
Quantity 5,483 -3.7%
Value US$27,415
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
4.66
Quantity 1,914 -3.9%
Value US$8,919
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
4.65
Quantity 5,548 -4.0%
Value US$25,798
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
4.77
Quantity 10,261 -5.3%
Value US$48,945
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
4.79
Quantity 3,154 -6.0%
Value US$15,108
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
6.75
Quantity 3,817 -1.9%
Value US$25,761
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
6.75
Quantity 1,858 -3.4%
Value US$12,540
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
1.11
Quantity 15,000 -0.6%
Value US$16,650
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
1.09
Quantity 12,000 -0.5%
Value US$13,080
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
1.09
Quantity 21,000 -0.8%
Value US$22,890
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
1.09
Quantity 228,000 -8.0%
Value US$248,520
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
1.51
Quantity 21,258 -0.7%
Value US$32,100
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
1.77
Quantity 14,030 -0.5%
Value US$24,833
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
1.79
Quantity 86,353 -2.9%
Value US$154,572
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
1.89
Quantity 38,197 -6.6%
Value US$72,307
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
2.51
Quantity 37,063 -6.0%
Value US$92,954
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
3.42
Quantity 48,790 -1.5%
Value US$166,745
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
3.66
Quantity 26,320 -5.2%
Value US$96,318
3.3
Oliviero James F III CEO, President and Director Executive Director
Transaction date
Sale
Price
3.51
Quantity 70,000 -2.1%
Value US$245,525
3.5
GRAY WILLIAM GARRETT Chief Financial Officer Officer
Transaction date
Sale
Price
2.79
Quantity 2,406 -0.7%
Value US$6,712
3.5
GRAY WILLIAM GARRETT See Remarks Officer
Transaction date
Sale
Price
2.00
Quantity 17,104 -4.5%
Value US$34,122
ROSENWALD LINDSAY A MD Non-Executive Director
Transaction date
Purchase
Price
1.27
Quantity 100,000 +72.5%
Value US$127,000
ROSENWALD LINDSAY A MD Non-Executive Director
Transaction date
Purchase
Price
2.35
Quantity 49,666 +64.7%
Value US$116,715
ROSENWALD LINDSAY A MD Non-Executive Director
Transaction date
Purchase
Price
2.24
Quantity 48,234 +169.0%
Value US$108,044
ROSENWALD LINDSAY A MD Non-Executive Director
Transaction date
Purchase
Price
2.12
Quantity 2,100 +7.9%
Value US$4,452
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-03 2025-05-29 S Sale
0.5
Fortress Biotech, Inc.
Large shareholder
33,730 +3.2%
31.11
US$3,962,542 		33,730 +3.2% 31.11 US$3,962,542
2025-04-03 2025-04-02 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
6,525 -5.8%
220.00
US$3,644,187 		6,525 -5.8% 220.00 US$3,644,187
2025-04-03 2025-04-01 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
66,455 +31.2%
154.36
US$1,700,838 		66,455 +31.2% 154.36 US$1,700,838
2025-02-11 2025-02-10 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
10,331 -0.3%
3.15
US$32,543 		10,331 -0.3% 3.15 US$32,543
2025-02-11 2025-02-07 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
9,233 -0.2%
3.41
US$31,485 		9,233 -0.2% 3.41 US$31,485
2025-02-07 2025-02-06 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
74,110 -4.8%
3.67
US$271,984 		74,110 -4.8% 3.67 US$271,984
2024-12-20 2024-12-19 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
220,230 -6.4%
3.38
US$744,377 		220,230 -6.4% 3.38 US$744,377
2024-12-20 2024-12-18 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
602,167 -15.0%
3.87
US$2,330,386 		602,167 -15.0% 3.87 US$2,330,386
2024-12-20 2024-12-18 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
268,432 -20.6%
4.01
US$1,076,412 		268,432 -20.6% 4.01 US$1,076,412
2024-06-28 2024-06-26 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
24,610 -1.2%
2.05
US$50,450 		24,610 -1.2% 2.05 US$50,450
2024-06-28 2024-06-26 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
13,038 -1.9%
2.06
US$26,858 		13,038 -1.9% 2.06 US$26,858
2024-03-01 2024-02-28 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
2,035 -1.4%
2.07
US$4,212 		2,035 -1.4% 2.07 US$4,212
2024-03-01 2024-02-28 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
5,894 -1.7%
2.06
US$12,142 		5,894 -1.7% 2.06 US$12,142
2024-02-02 2024-02-01 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
11,900 -3.1%
2.01
US$23,919 		11,900 -3.1% 2.01 US$23,919
2024-02-02 2024-02-01 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
4,115 -2.7%
1.95
US$8,024 		4,115 -2.7% 1.95 US$8,024
2023-03-03 2023-03-02 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
3,591 -6.5%
5.00
US$17,955 		3,591 -6.5% 5.00 US$17,955
2023-03-03 2023-03-02 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
5,483 -3.7%
5.00
US$27,415 		5,483 -3.7% 5.00 US$27,415
2023-03-03 2023-02-27 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
1,914 -3.9%
4.66
US$8,919 		1,914 -3.9% 4.66 US$8,919
2023-03-03 2023-02-27 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
5,548 -4.0%
4.65
US$25,798 		5,548 -4.0% 4.65 US$25,798
2023-02-03 2023-02-01 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
10,261 -5.3%
4.77
US$48,945 		10,261 -5.3% 4.77 US$48,945
2023-02-03 2023-02-01 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
3,154 -6.0%
4.79
US$15,108 		3,154 -6.0% 4.79 US$15,108
2023-01-12 2023-01-10 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
3,817 -1.9%
6.75
US$25,761 		3,817 -1.9% 6.75 US$25,761
2023-01-12 2023-01-10 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
1,858 -3.4%
6.75
US$12,540 		1,858 -3.4% 6.75 US$12,540
2022-07-01 2022-06-23 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
15,000 -0.6%
1.11
US$16,650 		15,000 -0.6% 1.11 US$16,650
2022-07-01 2022-06-22 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
12,000 -0.5%
1.09
US$13,080 		12,000 -0.5% 1.09 US$13,080
2022-07-01 2022-06-21 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
21,000 -0.8%
1.09
US$22,890 		21,000 -0.8% 1.09 US$22,890
2022-07-01 2022-06-17 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
228,000 -8.0%
1.09
US$248,520 		228,000 -8.0% 1.09 US$248,520
2022-04-22 2022-04-13 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
21,258 -0.7%
1.51
US$32,100 		21,258 -0.7% 1.51 US$32,100
2022-04-22 2022-04-05 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
14,030 -0.5%
1.77
US$24,833 		14,030 -0.5% 1.77 US$24,833
2022-04-22 2022-04-04 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
86,353 -2.9%
1.79
US$154,572 		86,353 -2.9% 1.79 US$154,572
2022-03-11 2022-03-10 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
38,197 -6.6%
1.89
US$72,307 		38,197 -6.6% 1.89 US$72,307
2022-02-02 2022-02-01 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
37,063 -6.0%
2.51
US$92,954 		37,063 -6.0% 2.51 US$92,954
2021-02-05 2021-02-05 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
48,790 -1.5%
3.42
US$166,745 		48,790 -1.5% 3.42 US$166,745
2021-02-05 2021-02-04 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
26,320 -5.2%
3.66
US$96,318 		26,320 -5.2% 3.66 US$96,318
2021-02-05 2021-02-04 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
70,000 -2.1%
3.51
US$245,525 		70,000 -2.1% 3.51 US$245,525
2020-12-23 2020-12-22 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
2,406 -0.7%
2.79
US$6,712 		2,406 -0.7% 2.79 US$6,712
2020-05-22 2020-05-21 S Sale
3.5
GRAY WILLIAM GARRETT

See Remarks

Officer
17,104 -4.5%
2.00
US$34,122 		17,104 -4.5% 2.00 US$34,122
2019-11-22 2019-11-20 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
100,000 +72.5%
1.27
US$127,000 		100,000 +72.5% 1.27 US$127,000
2018-11-13 2018-11-09 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
49,666 +64.7%
2.35
US$116,715 		49,666 +64.7% 2.35 US$116,715
2018-11-13 2018-11-08 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
48,234 +169.0%
2.24
US$108,044 		48,234 +169.0% 2.24 US$108,044
2018-11-13 2018-11-07 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
2,100 +7.9%
2.12
US$4,452 		2,100 +7.9% 2.12 US$4,452
Explore more

More insider trading research around Checkpoint Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America